Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The endogenous cannabinoid (eCB) system represents a major therapeutic target for the treatment of a variety of anxiety-related disorders. A recent study has demonstrated that pharmacologic or genetic disruption of CB1-receptor-mediated neurotransmission decreases the extinction of conditioned fear in mice. Here, we examined whether CB1 blockade would similarly disrupt extinction in rats, using fear-potentiated startle as a measure of conditioned fear. We also examined whether pharmacologic enhancement of CB1 activation would lead to enhancements in extinction. Our results indicate that systemic administration of the CB1 antagonist rimonabant (SR141716A) prior to extinction training led to significant, dose-dependent decreases in extinction. While the administration of the CB1 agonist WIN 55,212-2 did not appear to affect extinction, administration of AM404, an inhibitor of eCB breakdown and reuptake, led to dose-dependent enhancements in extinction. In addition to showing decreased fear 1 and 24 h after extinction training, AM404-treated animals showed decreased shock-induced reinstatement of fear. Control experiments demonstrated that the effects of AM404 could not be attributed to alterations in the expression of conditioned fear, locomotion, shock reactivity, or baseline startle, as these parameters seemed unchanged by AM404. Furthermore, coadministration of rimonabant with AM404 blocked this enhancement of extinction, suggesting that AM404 was acting to increase CB1 rece…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The endocannabinoid system has also been implicated in conditioned fear extinction and represents an additional area of exploration for facilitating extinction and prevention of fear return.”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [83]
In the citing paper
“Chhatwal et al. (83) showed that enhanced cannabinoid receptor CB1 activation (via administration of AM404, an agent that prevents endocannabinoid degradation and reuptake) facilitated within-session and between-session extinction of fear-potentiated startle as well as reinstatement in mice (83).”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [83]
In the citing paper
“Activating CB1R via systemic or intra-hippocampal or -mPFC administration of either the CB1R agonist, WIN55212-2, the ECB reuptake blocker, AM404, or AEA itself has been shown to facilitate rodent fear extinction, in most cases without affecting conditioned fear [89,95–98] (but see [90]).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [96]
Citations
Cites
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 1×
“Recent studies of CB1 knockout mice have demonstrated that the genetic deletion of the CB1 receptor leads to increased anxiety in several well-studied measures (Haller et al, 2002, 2004a, b; Martin et al, 2002).”
BackgroundRole of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · cited 3×
“Manipulation of the endogenous cannabinoid (eCB) system has become a major focus of current research, especially in the search for novel therapeutics to treat many common mental illnesses, including anxiety disorders, depression, and drug addiction (Porter and Felder, 2001; Kathuria et al, 2003).”
BackgroundResultKatona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 2×
“…by the dense expression of the CB1 receptor in regions known to be important for anxiety and emotional learning, including the amygdala, hippocampus, and throughout the mesolimbic dopamine reward system (Katona et al, 1999, 2000, 2001; Freund et al, 2003; van der Stelt and Di Marzo, 2003).”
BackgroundResultMemory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures
Suzuki, A., Josselyn, S. A., Frankland, P. W., Masushige, S., Silva, A. J., & Kida, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-03.2004 · Cited by 1,127
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Self-citationMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · cited 1×
“These hybridization results are in close agreement with previous studies using immunohistochemical and hybridization techniques (Katona et al, 1999; Marsicano and Lutz, 1999; McDonald and Mascagni, 2001).”
ResultBehavioral and Neural Analysis of Extinction
Myers, K. M., & Davis, M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01064-4 · Cited by 918 · cited 1×
“Reinstatement of fear is one of the principle behavioral processes upon which the idea is based that extinction does not lead to an ‘erasure’ of memory, but rather to a parallel inhibitory process that masks the previous fear memory (for a review, see Myers and Davis, 2002).”
BackgroundSelf-citationWalker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Self-citationFunctional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
Bouton, M. E., & King, D. A. (1983) · Journal of Experimental Psychology Animal Behavior Processes · doi:10.1037//0097-7403.9.3.248 · Cited by 769
Reinstatement of fear to an extinguished conditioned stimulus.
Rescorla, R. A., & Heth, C. D. (1975) · Journal of Experimental Psychology: Animal Behavior Processes · doi:10.1037//0097-7403.1.1.88 · Cited by 767
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala
Falls, W., Miserendino, M., & Davis, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-00854.1992 · Cited by 673 · cited 3×
“We and others have previously shown that extinction, which is known to be NMDA-dependent (Falls et al, 1992; Santini et al, 2001; Suzuki et al, 2004), can be enhanced with systemic or local administration into the amygdala of DCS, a partial NMDA agonist (Walker et al, 2002; Ledgerwood et al, 2003, 2004).”
BackgroundSelf-citationKatona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09506.2001 · Cited by 668 · cited 1×
“…by the dense expression of the CB1 receptor in regions known to be important for anxiety and emotional learning, including the amygdala, hippocampus, and throughout the mesolimbic dopamine reward system (Katona et al, 1999, 2000, 2001; Freund et al, 2003; van der Stelt and Di Marzo, 2003).”
BackgroundHeterosynaptic LTD of Hippocampal GABAergic Synapses
Chevaleyre, V., & Castillo, P. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00235-6 · Cited by 655
Neocortical LTD via Coincident Activation of Presynaptic NMDA and Cannabinoid Receptors
Sjöström, P. J., Turrigiano, G. G., & Nelson, S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00476-8 · Cited by 616
Involvement of CB1 cannabinoid receptors in emotional behaviour
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 507
Applying Learning Principles to the Treatment of Post‐Trauma Reactions
ROTHBAUM, B. O., & DAVIS, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1301.012 · Cited by 454
Self-citationMolecular characterization of human and mouse fatty acid amide hydrolases
Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429
Effects of D-cycloserine on extinction of conditioned freezing.
Ledgerwood, L., Richardson, R., & Cranney, J. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.2.341 · Cited by 388
Santini, E., Muller, R. U., & Quirk, G. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-09009.2001 · Cited by 358 · cited 1×
“We and others have previously shown that extinction, which is known to be NMDA-dependent (Falls et al, 1992; Santini et al, 2001; Suzuki et al, 2004), can be enhanced with systemic or local administration into the amygdala of DCS, a partial NMDA agonist (Walker et al, 2002; Ledgerwood et al, 2003,…”
BackgroundThe effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02192.x · Cited by 354 · cited 1×
“Recent studies of CB1 knockout mice have demonstrated that the genetic deletion of the CB1 receptor leads to increased anxiety in several well-studied measures (Haller et al, 2002, 2004a, b; Martin et al, 2002).”
BackgroundHerzberg, U., Eliav, E., Bennett, G. J., & Kopin, I. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13308-5 · Cited by 307 · cited 1×
“Notably, the well-documented emergence of prominent locomotor and analgesic effects following administration of higher doses of WIN (eg Tsou et al, 1996; Herzberg et al, 1997) limited our ability to test the effects of doses of WIN greater than 5 mg/kg.”
BackgroundInternalization and Recycling of the CB1 Cannabinoid Receptor
Hsieh, C., Brown, S., Derleth, C., & Mackie, K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730493.x · Cited by 296
van der Stelt, M., & Di Marzo, V. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.101 · Cited by 291
Haller, J., Varga, B., Ledent, C., Barna, I., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03293.x · Cited by 284
Lin, C.-H., Yeh, S.-H., Lu, H.-Y., & Gean, P.-W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08310.2003 · Cited by 251
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus
Katona, I., Sperlágh, B., Maglóczky, Z., Sántha, E., Köfalvi, A., Czirják, S., Mackie, K., Vizi, E. S., & Freund, T. F. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00286-4 · Cited by 244
Haller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241 · cited 1×
“Recent studies of CB1 knockout mice have demonstrated that the genetic deletion of the CB1 receptor leads to increased anxiety in several well-studied measures (Haller et al, 2002, 2004a, b; Martin et al, 2002).”
BackgroundReversal of Dopamine D2Receptor Responses by an Anandamide Transport Inhibitor
Beltramo, M., de Fonseca, F. R., Navarro, M., Calignano, A., Gorriti, M. A., Grammatikopoulos, G., Sadile, A. G., Giuffrida, A., & Piomelli, D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03401.2000 · Cited by 232
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400997101 · Cited by 230 · cited 1×
“AM404 and other inhibitors of the anandamide transporter, such as the newly identified AM1172 (Fegley et al, 2004), may enhance the process of extinction through an alternate mechanism.”
BackgroundThe endocannabinoid nervous system
Porter, A. C., & Felder, C. C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00130-9 · Cited by 227
Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
Giuffrida, A., Beltramo, M., & Piomelli, D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29345-9 · Cited by 226
Lu, K.-T., Walker, D. L., & Davis, M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-j0005.2001 · Cited by 222
Self-citationAzad, S. C., Eder, M., Marsicano, G., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2003) · Learning & Memory · doi:10.1101/lm.53303 · Cited by 220
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity
Mato, S., Chevaleyre, V., Robbe, D., Pazos, A., Castillo, P. E., & Manzoni, O. J. (2004) · Nature Neuroscience · doi:10.1038/nn1251 · Cited by 218
Regulation of Synaptic Plasticity Genes during Consolidation of Fear Conditioning
Ressler, K. J., Paschall, G., Zhou, X.-L., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07892.2002 · Cited by 217
Self-citationLedgerwood, L., Richardson, R., & Cranney, J. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.3.505 · Cited by 190
Agonist-Induced Internalization and Trafficking of Cannabinoid CB1Receptors in Hippocampal Neurons
Coutts, A. A., Anavi-Goffer, S., Ross, R. A., MacEwan, D. J., Mackie, K., Pertwee, R. G., & Irving, A. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02425.2001 · Cited by 175
Identification of Calcineurin as a Key Signal in the Extinction of Fear Memory
Lin, C.-H., Yeh, S.-H., Leu, T.-H., Chang, W.-C., Wang, S.-T., & Gean, P.-W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01574.2003 · Cited by 163
McDonald, A. J., & Mascagni, F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00380-3 · Cited by 157 · cited 1×
“These hybridization results are in close agreement with previous studies using immunohistochemical and hybridization techniques (Katona et al, 1999; Marsicano and Lutz, 1999; McDonald and Mascagni, 2001).”
ResultRole of the Amygdala in Fear Extinction Measured with Potentiated Startle
DAVIS, M., WALKER, D. L., & MYERS, K. M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07084.x · Cited by 152 · cited 1×
“The BLA has been repeatedly implicated in the extinction of conditioned fear in both direct pharmacological inactivation and augmentation studies (Falls et al, 1992; Walker et al, 2002; Davis et al, 2003).”
BackgroundSelf-citationThe design and calibration of a startle measurement system
Cassella, J. V., & Davis, M. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90032-6 · Cited by 139
Self-citationCannich, A., Wotjak, C. T., Kamprath, K., Hermann, H., Lutz, B., & Marsicano, G. (2004) · Learning & Memory · doi:10.1101/lm.77904 · Cited by 130
Jarrahian, A., Manna, S., Edgemond, W. S., Campbell, W. B., & Hillard, C. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742597.x · Cited by 129
Anandamide: an endogenous activator of the vanilloid receptor
Smart, D., & Jerman, J. C. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01459-0 · Cited by 120
Tsou, K., Lowitz, K., Hohmann, A. G., Martin, W. J., Hathaway, C. B., Bereiter, D. A., & Walker, J. M. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)83015-6 · Cited by 110
Cited by
Effects of an expanding-spaced vs massed exposure schedule on fear reduction and return of fear
Rowe, M. K., & Craske, M. G. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)10016-x · Cited by 1,676
Neural Mechanisms of Extinction Learning and Retrieval
Quirk, G. J., & Mueller, D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301555 · Cited by 1,645
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Myers, K. M., & Davis, M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001939 · Cited by 1,277
Self-citation
Metadata
- Authors
- Chhatwal, J. P., Davis, M., Maguschak, K. A., & Ressler, K. J.
- Affiliations
- Emory University (US)
- Corresponding author
- Ressler, Kerry J
- Venue
- Neuropsychopharmacology
- Published
- 2004-12-22
- Volume
- 30
- Issue
- 3
- Pages
- 516-524
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1987096289
- Cited by
- 376
- References
- 49
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 20 · 2022: 7 · 2021: 9 · 2020: 16 · 2019: 12 · 2018: 16 · 2017: 15 · 2016: 19 · 2015: 24 · 2014: 26 · 2013: 23 · 2012: 14
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation
- National Institutes of Health (MH47840)
- National Institute of Mental Health (MH 47840, F30MH070218, MH070218, MH69884, K01MH069884)
- National Institute of General Medical Sciences (T32GM008169)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, fear-potentiated startle, rimonabant, AM404, WIN 55,212-2, fear extinction, anxiety disorders, post-traumatic stress disorder, fear reconsolidation, emotional learning, exposure therapy
- MeSH terms
- Amygdala, Animals, Extinction, Psychological, Fear, Male, Synaptic Transmission, Rats, Sprague-Dawley, In Situ Hybridization, Receptor, Cannabinoid, CB1, Rats, Cannabinoid Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.